Impaired bone resorption by lipopolysaccharide in vivo in mice deficient in the prostaglandin E receptor EP4 subtype

Infection and Immunity

Volumn 68, Issue 12, 2000, Pages 6819-6825

  Sakuma, Yoko ^a   Tanaka, Kiyoshi ^a   Suda, Michio ^a   Komatsu, Yasato ^a   Yasoda, Akihiro ^a   Miura, Masako ^a   Ozasa, Ami ^a   Narumiya, Shuh ^a   Sugimoto, Yukihiko ^a   Ichikawa, Atsushi ^a   Ushikubi, Fumitaka ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PROSTAGLANDIN E RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOMYELITIS; PATHOPHYSIOLOGY; PERIODONTITIS; PRIORITY JOURNAL;

ANIMALS; BONE RESORPTION; CARRIER PROTEINS; DINOPROSTONE; FEMALE; GLYCOPROTEINS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 0034440540     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.12.6819-6825.2000     Document Type: Article

References (46)

1. Abu-Amer, Y., F. P. Ross, J. Edwards, and S. L. Teitelbaum. 1997, Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its p55 receptor. J. Clin. Investig. 100:1557-1565.
2. Agarwall, S., N. P. Piesco, L. P. Johns, and A. E. Riccelli. 1995. Differential expression of IL-1 beta, TNF-alpha, IL-6, IL-8 in human monocytes in response to lipopolysaccharides from different microbes. J. Dent. Res. 74: 1057-1065.
3. Aznar, C., C. Fitting, and J. M. Cavaillon. 1990. LPS-induced production of cytokines by bone marrow-derived macrophages: destruction between intracellular IL-1 production and IL-1 release. Cytokine 2:259-265.
4. Birkeadal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28:500-510.
5. Bom-van Noorloos, A. A., J. W. van der Merr, J. S. van de Gevel, E. Schepens, T. J. van Steenbergen, and E. H. Burger. 1990. Bacteroides gingivalis stimulates bone resorption via interleukin production by mononuclear cells. The relative role for B. gingivalis endotoxin. J. Clin. Periodontol. 17:409-413.
6. Bucay, N., I. Sasori, C. R. Dundtan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, W. J. Boyle, and W. S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260-1268.
7. Casari, E., M. Alfano, G. D. Clarke, G. Ferni, and B. Grazioli. 1997. Ovarectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues. Osteoporos. Int. 7:539-543.
8. Chambers, T. J. 1991. Regulation of osteoclast development and function, p. 105-128. In B. R. Rifkin and C. V. Gay (ed.), Biology and physiology of the osteoclast. CRC Press, Boca Raton, Fla.
9. Chiang, C. H., G. Kyritsis, D. T. Graves, and S. Amar. 1999. Interleukin-1 and tumor necrosis factor avtivities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect. Immun. 67:4231-4236.
10. Coleman, R. A., W. L. Smith, and S. Narumiya. 1994. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:205-209.
11. Hausmann, E., N. Weinfeld, and W. A. Miller. 1972. Effect of lipopolysaccharide on bone resorption in tissue culture. Calcif. Tissue Res. 9:272-282.
12. Hausmann, E., L. G. Raisz, and W. A. Miller. 1970. Endotoxin: stimulation of bone resorption in tissue culture. Science 168:862-864.
13. Holt, S. C., and J. L. Ebersole. 1991. The surface of selected periodontopathic bacteria: possible role in virulence, p. 981-991. In S. Hamada, S. C Holt, and J. R. McGhee (ed.), Periodontal disease, vol. 79. Pathogens and host immune responses. Quintessence Publishing Co., Ltd., Tokyo, Japan.
14. Honda, A., Y. Sugimoto, T. Namba, A. Watabe, A. Irie, M. Negishi, S. Narumiya, and A. Ishikawa. 1993. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem. 268:7759-7762.
15. Howell, T. H., and R. C. Williams. 1993. Nonsteroidal antiflammatory drugs as inhibitors of periodontal disease progression. Crit. Rev. Oral Biol. Med. 4:177-196.
16. Ishihara, Y., T. Nishihara, E. Maki, T. Noguchi, and T. Koga. 1991. Role of interlrukin-1 and prostaglandin in in-vitro bone resorption induced by actinobacillus-actinomycetemcomitans lipopolysaccharide. J. Periodontal Res. 26:155-160.
17. Kadono, H., J. Kido, M. Kataoka, N. Yamauchi, and T. Nagata. 1999. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect. Immun. 67:2841-2846.
18. Katsuyama, M., N. Nishigaki, Y. Sugimoto, K. Morimoto, M. Negishi, S. Narumiya, and A. Ichikawa. 1995. The mouse prostaglandin E receptor EP2 subtypes: cloning, expression and Northern blot analysis. FEBS Lett. 372: 151-156.
19. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 2000. OPGL is a key factor of osteoclastgenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
20. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelly, C. R. Dunstan, T. Burgess, R. Elicott, A. Colombero, G. E. S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Delaney, and W. J. Boyle. 1998. Osteoprogerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
21. Lane, N. E., J. M. Thompson, D. Haupt, D. B. Kimmel, G. Modin, and J. H. Kinney. 1998. Acute changes in travecular bone connectivity and osteoclast activity in the ovarectomized rat in vivo. J. Bone Miner. Res. 13:229-236.
22. Meryon, S. D., and A. D. Perris. 1981. Lipopolysaccharide-induced bone resorption is mediated by prostaglandins. Life Sci. 28:1061-1065.
23. Mundy, G. R., and G. D. Roodman. 1987. Osteoclast ontogeny and function, annual 5, p. 209-279. In W. A. Peck (ed.), Bone and mineral research. Elsevier, Amsterdam, The Netherlands.
24. Nair, S. P., S. M. Meghji, M. Wilson, K. Reddi, P. White, and B. Henderson. 1996. Bacterial induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64:2371-2380.
25. Nguyen, M., T. Camenisch, J. N. Snouwaert, E. Hicks, T. M. Coffman, P. A. W. Anderson, N. N. Malouf, and B. H. Koller. 1997. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390:78-81.
26. Orcel, P., M. Feuga, J. Bielakoff, and M. C. De Vernejoul. 1993. Local bone injections of LPS and M-CSF increase bone resorption by different pathways in vivo in rats. Am. J. Physiol. 264:E391-397.
27. Pilbeam, C. C., J. R. Harrison, and L. G. Raisz. 1996. Prostaglandins and bone metabolism, p. 715-728. In J. P Bilezikian, L. G. Raisz, and G. A. Rodan (ed.), Principles of bone biology. Academic Press, San Diego, Calif.
28. Plotquin, D., S. Dekel, S. Katz, and A. Danon. 1991. Prostaglandin release by normal and osteomyelitic human bones. Prostaglandins Leukot. Essent. Fatty Acids 43:13-15.
29. Raisz, L. G. 1995. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J. Nutr. 125:2024S-2027S.
30. Sakuma, Y., K. Tanaka, M. Suda, A. Yasoda, K. Natsui, I. Tanaka, F. Ushikubi, S. Narumiya, E. Segi, V. Sugimoto, A. Ichikawa, and K. Nakao. 2000. Crucial involvement of the EP4 subtype of prostaglandin E (PGE) receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide. J. Bone Miner. Res., 15:218-227.
31. Salvi, G. E., R. C. Williams, and S. Offenbacher. 1997. Nonsteroidal antiinflammatory drugs as adjuncts in the manegement of periodontal diseases and peri-implantitis. Curr. Opin. Periodontol. 4:51-58.
32. Segi, E., Y. Sugimoto, A. Yamasaki, Y. Aze, H. Oida, T. Nishimura, T. Murata, T. Matsuoka, F. Ushikubi, M. Hirose, T. Tanaka, N. Yoshida, S. Narumiya, and A. Ichikawa. 1998. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem. Biophys. Res. Commun. 246:7-12.
33. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luethy, H. Q. Nguen, S. Wooden, L. Bennett, and T. Bonne. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 64:693-702.
34. 3 in osteoclast differentiation and function. Methods Enzymol. 282:223-235.
35. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrinol. Rev. 20:345-357.
36. Suda, T., N. Udagawa, and N. Takahashi. 1996. Cells of bone: osteoclast generation, p. 87-102. In J. P. Bilezikian, L. G. Raisz, and G. A. Rodan (ed.), Principles of bone biology. Academic Press, San Diego, Calif.
37. Sugimoto, Y., T. Namba, T. Honda, Y. Hayashi, M. Negishi, A. Ichikawa, and S. Narumiya. 1992. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem. 267:6463-6466.
38. 2, or parathyroid hormone in the microenvironment of bone. Biochem. Biophys. Res. Commun. 246:337-341.
39. Udagawa, N., N. Takahashi, T. Akatsu, H. Tanaka, T. Sasaki, T. Nishihara, T. Koga, T. J. Martin, and T. Suda. 1990. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA 87:7260-7264.
40. Uebelhart, D., E. Gineyts, M. C. Chapuy, and P. D. Delmas. 1990. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone desease. Bone Miner. 8:87-96.
41. Ueda, N., M. Koide, M. Ohguchi, Y. Ishihara, T. Noguchi, N. Okahashi, and T. Nishihara. 1998. Involvement of prostaglandin E2 and interleukin-1 alpha in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J. Periodontal Res. 33:509-516.
42. Watabe, A., Y. Sugimoto, A. Honda, A. Irie, T. Namba, M. Negishi, M. Ito, S. Narumiya, and A. Ichikawa. 1993. Cloning and expresion of cDNA for a mouse EPl subtype of prostaglandin E receptor. J. Biol. Chem. 268:20175-20178.
43. Williams, R. C., M. K. Jeffcoat, M. L. Kaplan, P. Goldhaber, H. G. Johnson, and W. J. Wechter. 1985. Flurbiprofen: a potent inhibitor of alveolar bone resorption in beagles. Science 227:640-642.
44. Yasuda, H., N. Shima, N. Nakagawa, S. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. Goto, K. Yamaguchi, M. Kuriyama, T. Kanno, A. Murakami, E. Tsuda, T. Morinaga, and K. Higashio. 1998. Identify of osteoclast inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/ OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337.
45. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597-3602.
46. Zubery, Y., C. R. Dunstan, M. Story, L. Kesavalu, J. L. Ebersole, S. C. Holt, and B. F. Boyce. 1999. Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin. Infect. Immun. 66:4158-4162.